Heqet Therapeutics
PrivateLast Round
Series A
Mar 23, 2022
Total Funding Raised
$8.7M
Company Overview
Heqet Therapeutics is a biotechnology company that develops non-coding RNA-based therapies for cardiovascular diseases, with a particular emphasis on acute myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heqet Therapeutics Comparables
Compare Heqet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolifagen | 85% | |
| Jaan Biotherapeutics | 84% | |
| Summa Biotech BV | 84% |
Heqet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2022 |
Heqet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deutsche Balaton | Series A |
| Claris Ventures | Series A |
| 2invest AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 122% MoM, reaching 1.1K.
- Nov 18, 2024
Monthly visitors increased 45% MoM.
Heqet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Heqet Therapeutics's valuation, stock price, and market status.
Is Heqet Therapeutics a public or private company?
Heqet Therapeutics is a private company.
What is the current stock price of Heqet Therapeutics?
Heqet Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Heqet Therapeutics worth (valuation)?
Valuation information for Heqet Therapeutics is not publicly available.
Can I buy Heqet Therapeutics stock?
Heqet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Heqet Therapeutics's last funding round?
Heqet Therapeutics's most recent funding round was Series A on March 23, 2022.
Who are the main investors in Heqet Therapeutics?
Key investors in Heqet Therapeutics include Claris Ventures, 2invest AG.
Will Heqet Therapeutics IPO soon?
No public IPO plans have been announced for Heqet Therapeutics.
How can I track Heqet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Heqet Therapeutics's secondary market activity and sign up for updates.